Roles of endothelin-1 in beta-amyloid-induced neurotoxicity in hippocampus: an implication for Alzheimer’s pathology by Tam, SW et al.
Title Roles of endothelin-1 in beta-amyloid-induced neurotoxicity inhippocampus: an implication for Alzheimer’s pathology
Author(s) Tam, SW; Chung, SK; Law, ACK
Citation
The 2015 Conference of the British Neuroscience Association
(BNA 2015), Edinburgh, UK., 12-15 April 2015. In Abstract Book,
2015, p. 735, abstract no. P3-F-012
Issued Date 2015
URL http://hdl.handle.net/10722/210569






Poster Ref: P3-F-012 
Theme: F: Nervous System Disorders 
 
Roles of endothelin-1 in beta-amyloid-induced neurotoxicity in hippocampus: An implication for Alzheimer’s pathology.  
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¹The University of Hong Kong, ²Department of Anatomy, the University of Hong Kong, ³Department of Psychiatry, the 
University of Hong Kong 
 
Alzheimer’s disease (AD) is an incurable neurodegenerative disorder. Abnormal levels of endothelin-1 (ET-1) have been 
demonstrated in parietal white matter(1), cerebral cortex and vessels of the AD brain(2). Neuronal death and 
accumulation of beta-amyloid (Aβ) are prominent pathological features of AD. Significant neuronal death is found in Aβ-
treated primary neurons and Aβ-overexpressing mouse models(3,4). ET-1 is a known vasoconstrictor and neuro-active 
peptide. ET-1 induces apoptosis in primary retinal neurons(5).  In contrary, ET-receptor (ETR) type B agonist can rescue 
neurons from Aβ-induced apoptosis(6).   These findings suggest ET-1 plays dual roles in neurodegeneration and 
neuroprotection, respectively. This study aims to investigate the effect of ET-1 on Aβ-induced cell death in hippocampal 
neurons.  
 
Primary hippocampal neurons were pretreated with or without ETR antagonists prior to the treatment of oligomeric form 
of Aβ1-42, ET-1 or both on 14 DIV. Cell viability was measured by MTT assay. Changes in protein expression in 
apoptotic and ET-1 signaling pathways were assessed by western-blot analysis. This study shed light on the roles of ET-
1 in Aβ1-42-neurotoxicity, building upon which the ET-1 signaling pathway as a potential therapeutic target for AD can be 
further investigated. 
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